Dr. Jian’an Wang has been named as the inaugural editor-of-chief of JACC: Asia, the American College of Cardiology’s newest addition to its journal portfolio. The Journal will publish original manuscripts and clinical practice guidelines specific to Asian populations and by Asian authors.
Wang is a physician scientist who serves as the chair of the Heart Center at the Second Affiliated Hospital at Zhejiang University School of Medicine in China. He is also a professor and associate dean at Zhejiang University School of Medicine.
A leading interventional cardiologist, Wang has spearheaded the efforts in establishing and developing one of the largest valvular heart disease programs in Asia. Wang has also developed several innovative devices for valvular interventions, in collaboration with engineers, cardiovascular colleagues and manufacturers, that have been approved by the China Food and Drug Administration. His research work focuses on improving the efficacy of stem cell implantation in infarcted myocardium through hypoxemic preconditioning, which has been validated on rodent model, non-human primate model and phase-1 clinical studies.
Announced in July, JACC: Asia will be the first region-specific cardiovascular journal with original peer-reviewed content. The publication will be an online-only Open Access journal covering topics ranging from cardiovascular health and prevention to late-stage interventions specifically within East Asian populations. The Journal will also feature clinical practice guideline recommendations focused on Chinese, Japanese and South Korean patients who have or are at risk of developing cardiovascular disease.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
Click here to read the original press release.
